Associated Papers
KCNJ5 mutations in familial and non-familial primary aldosteronism.
Al-Salameh A
European Journal of Endocrinology, 2024
Pathophysiology of bilateral hyperaldosteronism.
Nanba K et al.
Current Opinion in Endocrinology, Diabetes, and Obesity, 2022
A novel small-molecule selective activator of homomeric GIRK4 channels.
Cui M et al.
The Journal of Biological Chemistry, 2022
Determinants of trafficking, conduction, and disease within a K+ channel revealed through multiparametric deep mutational scanning.
Coyote-Maestas W et al.
Elife, 2022
A revised mechanism of action of hyperaldosteronism-linked mutations in cytosolic domains of GIRK4 (KCNJ5).
Shalomov B et al.
The Journal of Physiology, 2022
How do Kir3.4 mutations cause hereditary hyperaldosteronism?
Kubo Y
The Journal of Physiology, 2022
Pathogenesis of Primary Aldosteronism: Impact on Clinical Outcome.
Santana LS et al.
Frontiers in Endocrinology, 2022
Progress on Genetic Basis of Primary Aldosteronism.
Karwacka I et al.
Biomedicines, 2021
Familial hyperaldosteronism type III a novel case and review of literature.
Pons Fernández N et al.
Reviews in Endocrine & Metabolic Disorders, 2019
Inherited Forms of Primary Hyperaldosteronism: New Genes, New Phenotypes and Proposition of A New Classification.
Perez-Rivas LG et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association, 2019
GENETICS IN ENDOCRINOLOGY: The expanding genetic horizon of primary aldosteronism.
Monticone S et al.
European Journal of Endocrinology, 2018
Familial hyperaldosteronism type III.
Monticone S et al.
Journal of Human Hypertension, 2017
Somatic and inherited mutations in primary aldosteronism.
Fernandes-Rosa FL et al.
Journal of Molecular Endocrinology, 2017
Genetics of primary hyperaldosteronism.
Dutta RK et al.
Endocrine-related Cancer, 2016
[Genetic alterations in primary aldosteronism].
Zennaro MC et al.
Medecine Sciences : M/s, 2015
KCNJ5 mutations are the most frequent genetic alteration in primary aldosteronism.
Williams TA et al.
Hypertension (dallas, Tex. : 1979), 2015
Understanding primary aldosteronism: impact of next generation sequencing and expression profiling.
Monticone S et al.
Molecular and Cellular Endocrinology, 2015
Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance.
Cheng CJ et al.
The Journal of Clinical Endocrinology and Metabolism, 2015
Update in primary aldosteronism.
Stowasser M
The Journal of Clinical Endocrinology and Metabolism, 2015
A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium.
Kuppusamy M et al.
The Journal of Clinical Endocrinology and Metabolism, 2014
Role for germline mutations and a rare coding single nucleotide polymorphism within the KCNJ5 potassium channel in a large cohort of sporadic cases of primary aldosteronism.
Murthy M et al.
Hypertension (dallas, Tex. : 1979), 2014
Overview of the genetic determinants of primary aldosteronism.
Al-Salameh A et al.
The Application of Clinical Genetics, 2014